Nature Medicine today featured on its cover the findings from The Feinstein Institutes for Medical Research, demonstrating ...

Mission Therapeutics has divested MTX652, a Phase 2-ready selective USP30 inhibitor for Acute Kidney Injury (AKI), to ASX-listed renal specialist Dimerix Limited (ASX: DXB)Mission will receive up to U ...

Beer sales, as measured by production and imports, has been steadily falling in the U.S. as consumers focus on health and trim discretionary purchases. Some have also changed how they socialize with ...